EMA expects to review data on Bayer's Diane-35; U.K. study adds to data on GSK shot's narcolepsy links;

@FiercePharma: EMA sounds a bit perturbed about France's suspension of Diane-35. But it will review data when France asks. More | Follow @FiercePharma

 @AlisonBFierce: Life Technologies established an international flu network to develop a speedy monitoring system and better vaccine. News | Follow @AlisonBFierce

@EricPFierce: BASF says it has finally gotten the Pronova deal closed making it one of the largest fish oil producers in the world. Release | Follow @EricPFierce

> The European Medicines Agency expects France to request a safety review of Bayer's acne drug Diane-35, which French authorities suspended yesterday. Report

> A U.K. study joined research from Sweden and Finland in drawing links between GlaxoSmithKline's ($GSK) Pandemrix vaccine and cases of the rare sleep disorder narcolepsy. Report

> Japan's Daiichi Sankyo, which owns a majority stake in India's Ranbaxy Laboratories, reported 9-month profits that almost tripled year-over-year because of legal charges in the previous period. Report

> A Pennsylvania woman sued Bayer, claiming the German company failed to warn of serious risks with its intrauterine contraceptive Mirena. Report

> Fitch Ratings raised Roche ($RHHBY) to a "AA," citing its market-leading position in the fast-growing oncology segment and limited exposure to patent expirations. Report

Biotech News

 @FierceBiotech: Celsion shares routed after PhIII liver cancer study flops. News | Follow @FierceBiotech

@JohnCFierce: AstraZeneca's Soriot is going to have to do something bold, something dramatic, and something a little loony. In that order. | Follow @JohnCFierce

@RyanMFierce: Holland's health minister is sounding very German on drug pricing, wants to chop cost of Genzyme and Shire therapies. More | Follow @RyanMFierce

> Venture firm preps $100M fund for late-stage life sciences investments. News

> Vanda slides after drug fails PhII/III for depression. Item

> Is AstraZeneca getting ready to buy a pipeline? Report

> Pharmaxis suffers FDA committee upset, nabs up to $40M in financing. Article

> Genentech flashes PhIII progress for prized Rituxan successor. Story

Medical Device News

 @FierceMedDev: Startup brings molecular diagnostics to India's swelling market. Article | Follow @FierceMedDev

 @MarkHFierce: Today's Dx Extra: Another company will take on development of an RA Dx. Story | Follow @MarkHFierce

 @DamianFierce: After a weak Q4, Zimmer's counting on restructuring to save 2013 profits. News | Follow @DamianFierce

> Cardiovascular Systems PAD treatment tech kickstarts revenue growth. Story

> Tyrx's dissolvable antibacterial envelope wins Canadian approval. Report

Vaccines News

> MIT explores DNA vaccine delivery. Item

> Life establishes international flu network. More

> CDC: Adult vaccination rates 'unacceptably low.' Report

> FDA expands use of Pfizer's Prevnar 13. Article

> GSK, Biological E partner on childhood vaccine. Story

Pharma Manufacturing News

> Cargo theft up dramatically in Mexico. Item

> Sanofi's Genzyme looking hard at continuous manufacturing. News

> Biogen, Merck, Novartis, others have plants recognized for innovations. More

> Teva, P&G start on OTC plant in India. Story

And Finally... Here's how morale goes into a downward spiral: Rude behavior at work is increasing--and it prompts co-workers to dial back their efforts, a study found. Report

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.